Ophthalmic Plastic and Reconstructive Surgery

Papers
(The H4-Index of Ophthalmic Plastic and Reconstructive Surgery is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Acute Invasive Rhino-Orbital Mucormycosis in a Patient With COVID-19-Associated Acute Respiratory Distress Syndrome180
Clinical Presentations, Management and Outcomes of Rhino-Orbital-Cerebral Mucormycosis (ROCM) Following COVID-19: A Multi-Centric Study64
Teprotumumab and Hearing Loss: Case Series and Proposal for Audiologic Monitoring39
ChatGPT and Lacrimal Drainage Disorders: Performance and Scope of Improvement39
Thyroid Eye Disease Following COVID-19 Vaccine in a Patient With a History Graves’ Disease: A Case Report37
Early Experience With the Clinical Use of Teprotumumab in a Heterogenous Thyroid Eye Disease Population33
Teprotumumab for Dysthyroid Optic Neuropathy: Early Response to Therapy27
New-Onset of Inflammatory Bowel Disease in a Patient Treated With Teprotumumab for Thyroid Associated Ophthalmopathy22
Orbital Vascular Anomalies: A Nomenclatorial, Etiological, and Nosologic Conundrum17
Anti-inflammatory and Antioxidant Effects of Selenium on Orbital Fibroblasts of Patients With Graves Ophthalmopathy15
Management of Pediatric Acute Dacryocystitis15
Telemedicine in Oculoplastics: The Real-Life Application of Video Consultation Clinics11
Teprotumumab and Hyperglycemia Guidelines to Monitor for Hyperglycemia in Teprotumumab11
Intraocular Pressure and Glaucoma in Thyroid Eye Disease11
Perioperative Considerations for Antithrombotic Therapy in Oculofacial Surgery: A Review of Current Evidence and Practice Guidelines11
Transient Eyelid Edema Following COVID-19 Vaccination11
0.037170886993408